AMCP Live Simulcast: The Evolving Landscape of Insulin-Dependent Diabetes Mellitus: Clinical, Cost, and Coverage Considerations for Continuous Glucose Monitoring

AMCP Live Simulcast: The Evolving Landscape of Insulin-Dependent Diabetes Mellitus: Clinical, Cost, and Coverage Considerations for Continuous Glucose Monitoring

Live Webinar
Program Details

Monday, October 16, 2017

5:30 - 7:00 pm CT (6:30 - 8:00 pm ET)

Live AMCP CPE/CME-accredited Interactive Dinner Symposium Simulcast from the convenience of your home computer!

Held in conjunction with

AMCP Nexus 2017






H. Eric Cannon, PharmD, FAMCP
VP Pharmacy Benefits
Murray, Utah

Sam Ellis, PharmD, BCPS, CDE
Associate Professor
Department of Clinical Pharmacy
Skaggs School of Pharmacy and Pharmaceutical Sciences
Anschutz Medical Campus
University of Colorado
Aurora, Colorado

Intended Learners

This activity is designed for pharmacy directors, medical directors, and other decision makers working in managed care organizations.

Learning Objectives

After completing this activity, participants should be able to:

  • Describe the clinical and economic impact of uncontrolled blood glucose in patients with insulin-dependent diabetes
  • Identify the limitations of SMBG and populations that may benefit from CGM
  • Evaluate current and new CGM technologies in terms of indications, technical features, benefits and limitations, data sharing, accuracy, and clinical outcomes
  • Integrate recent CGM approvals, outcomes data, and CMS policy changes into informed clinical and coverage decisions
Activity Overview

This interactive dinner symposium will occur at AMCP Nexus 2017 in the Gaylord Texan Hotel and Convention Center, Dallas, TX on Monday, October 16, from 5:00 pm to 7:00 pm CT. A question-and-answer session with the faculty will follow the presentation.

To be eligible for documentation of credit, participants must attend the live activity and submit a completed evaluation form.  All individuals who participate in the full symposium and submit an evaluation will receive documentation of credit via email within 8 weeks.

ACPE Credit Policy

The certificate is not the official record of your participation in the activity. The official record of credit will be the information in CPE Monitor system.

Eligibility for pharmacy credit is contingent upon the successful completion of a post-test and/or evaluation for each activity or session attended. The reporting function into CPE Monitor will only be available for 60 days after your completion of the activity.  Under ACPE Policy, NACCME will not be able to report your credit to CPE Monitor after this 60 day period.

For questions regarding this educational activity, please call 609-371-1137.

No additional fee is required to attend this activity.

Hardware/Software Requirements

All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested for video programs (please download here). A PDF reader is required for print publications. Please direct technical questions to


  In support of improving patient care, North American Center for Continuing Medical Education (NACCME) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.







NACCME designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.


This live activity is approved for 1.5 contact hours (.15 CEUs) of continuing pharmacy education (UAN 0276-0000-17-104-L01-P).

This educational activity is a knowledge-based activity.

Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Senior Manager, Accreditation & Compliance, NACCME, in writing at 104 Windsor Center Drive, Suite 200, East Windsor, NJ 08520. The Senior Manager, Accreditation & Compliance will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Senior Director, Accreditation and Compliance, NACCME, may be made for a second level of review.

 Independent Clinical Reviewer: Kyle R. Copeland, PharmD, BCPS, Clinical Specialist Pharmacist, Parkwest Medical Center and Assistant Professor, University of Tennessee College of Pharmacy, Knoxville, Tennessee.

Planning Committee

The planning committee comprises Eric Cannon, PharmD, FAMCP, Kyle R. Copeland, PharmD, BCPS, Sam Ellis, PharmD, BCPS, CDE; Donna Brophy, Jennifer Browne, Mary Johnson, Kristin Ciszeski, Randy Robbin, John Savage, and Sydney Turner, NACCME.

Financial Disclosure and Conflicts of Interest

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.

The faculty has reported the following:

Dr. Cannon: ConsultantAbbVie, Gilead

Dr. Copeland has disclosed no relevant financial relationships with any commercial interest.

Dr. Ellis: Disclosure will be provided prior to the activity.

Ms. Brophy, Ms. Browne, Ms. Johnson, Ms. Ciszeski, Mr. Robbin, Mr. Savage, and Ms. Turner have disclosed no relevant financial relationships with any commercial interests.

NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.

ADA Statement

North American Center for Continuing Medical Education complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2017 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

Grant Support

This activity has been supported by an educational grant from Dexcom, Inc.